Prostacyclin
Showing 1 - 25 of 257
Pulmonary Vascular Disease Trial in Durham (Hyperpolarized 129Xenon gas)
Recruiting
- Pulmonary Vascular Disease
- Hyperpolarized 129Xenon gas
-
Durham, North CarolinaDuke University Medical Center
Oct 3, 2022
Pulmonary Arterial Hypertension Trial in Tempe (Prostacyclin Receptor Agonist)
Recruiting
- Pulmonary Arterial Hypertension
- Prostacyclin Receptor Agonist
-
Tempe, ArizonaCelerion
Aug 16, 2022
Diabetes, Type 2, Diabetic Foot Trial in Grenoble (Microdialysis, current induced vasodilation, Skin biopsy, peri-ulcerated skin
Recruiting
- Diabetes Mellitus, Type 2
- Diabetic Foot
- Microdialysis, current induced vasodilation
- +2 more
-
Grenoble, FranceCHU Grenoble Alpes Centre d'investigation clinique
Nov 2, 2022
Pulmonary Arterial Hypertension Trial in Spain (No intervention - Observational study)
Recruiting
- Pulmonary Arterial Hypertension
- No intervention - Observational study
-
El Ejido, Almería, Spain
- +9 more
Nov 2, 2022
Pulmonary Arterial Hypertension Trial (Selexipag, Riociguat, CardioMEMS pulmonary artery pressure monitor)
Not yet recruiting
- Pulmonary Arterial Hypertension
- Selexipag
- +3 more
- (no location specified)
Apr 11, 2023
COVID-19, Respiratory Failure Trial in Denmark (Iloprost, Isotonic saline)
Completed
- COVID-19
- Respiratory Failure
- Iloprost
- Isotonic saline
-
Copenhagen, Denmark
- +4 more
Dec 8, 2021
Surgery Trial in Copenhagen (Prostacycline, Isotonic saline)
Completed
- Surgery
- Prostacycline
- Isotonic saline
-
Copenhagen, Zealand, DenmarkRigshospitalet
Mar 9, 2021
Cardiac Arrest Trial in Copenhagen (Iloprost, Saline, Phillips M1006B, offset by -10mmHg)
Completed
- Cardiac Arrest
- Iloprost
- +3 more
-
Copenhagen, DenmarkDept. of Cardiology, 2143, Rigshospitalet
Mar 9, 2021
Prostacyclin Analogues in Pulmonary Arterial Hypertension
Completed
- Pulmonary Hypertension
-
Warsaw, PolandDepartment of Pulmonary Circulation, Thromboembolic Diseases and
Oct 8, 2020
Pulmonary Arterial Hypertension Trial in Nancy, Le Kremlin-Bicêtre, Gießen (Inhaled dry powder treprostinil (LIQ861))
Terminated
- Pulmonary Arterial Hypertension
- Inhaled dry powder treprostinil (LIQ861)
-
Nancy, Vandoeuvre Les Nancy, France
- +2 more
Sep 3, 2021
Primary Pulmonary Hypertension Trial in United States (LIQ861 Inhaled Treprostinil)
Active, not recruiting
- Primary Pulmonary Hypertension
- LIQ861 Inhaled Treprostinil
-
Phoenix, Arizona
- +24 more
Aug 26, 2021
Pulmonary Hypertension Trial in Aswan (Treprostinil)
Recruiting
- Pulmonary Hypertension
-
Aswan, EgyptAswan Heart Centre - Magdi Yacoub Heart Foundation
Dec 14, 2022
Chronic Thromboembolic Pulmonary Hypertension, CTEPH Trial in Worldwide (Balloon pulmonary angioplasty)
Completed
- Chronic Thromboembolic Pulmonary Hypertension
- CTEPH
- Balloon pulmonary angioplasty
-
La Jolla, California
- +17 more
Jun 9, 2022
Next Generation Infusion Pumps to Administer Remodulin
Not yet recruiting
- Pulmonary Arterial Hypertension
- Remunity Pump for Remodulin
- (no location specified)
Dec 29, 2022
Objective Grading of MTS With LSCI and Thermography
Recruiting
- Mesenteric Traction Syndrome
-
København Ø, Hovedstaden, DenmarkRigshospitalet
Oct 31, 2022
Mechanisms of Pregnancy Vascular Adaptations
Recruiting
- Pre-Eclampsia
- Vascular Diseases
- Omental Biopsy
-
Madison, WisconsinUnityPoint Health-Meriter Hospital
Nov 1, 2022
Sarcoidosis-associated Pulmonary Hypertension Trial in Worldwide (Selexipag, Placebo)
Active, not recruiting
- Sarcoidosis-associated Pulmonary Hypertension
- Selexipag
- Placebo
-
Indianapolis, Indiana
- +38 more
Jan 31, 2023
Pulmonary Arterial Hypertension Trial in Kansas City (Placebo, Seralutinib, Generic Dry Powder Inhaler)
Not yet recruiting
- Pulmonary Arterial Hypertension
- Placebo
- +2 more
-
Kansas City, KansasUniversity of Kansas Medical Center
Jun 28, 2023
Raynaud's Phenomenon Trial in Boston (oral treprostinil, Placebo)
Completed
- Raynaud's Phenomenon
- oral treprostinil
- Placebo
-
Boston, MassachusettsBrigham and Women's Hospital
Jan 5, 2022
Endothelial Dysfunction, Nutritional Status, Quality of Life Trial (Non-alcoholic beer, control)
Completed
- Endothelial Dysfunction
- +2 more
- Non-alcoholic beer
- control
- (no location specified)
Aug 31, 2022
Identify Mechanisms of Menopause on Cardiovascular Disease Risk
Not yet recruiting
- Menopause
- +3 more
-
Copenhagen, DenmarkDeparment of Nutrition, Exercise and Sports
Dec 3, 2022
Healthy Trial in Philadelphia (Celecoxib, Naproxen, Placebo)
Terminated
- Healthy
- Celecoxib
- +2 more
-
Philadelphia, PennsylvaniaInstitute for Translational Medicine and Therapeutics (ITMAT), U
Oct 20, 2022
Pulmonary Hypertension Trial in Edmonton (Vasopressin infusion, Vasopressin infusion and epoprostenol inhalation)
Terminated
- Pulmonary Hypertension
- Vasopressin infusion
- Vasopressin infusion and epoprostenol inhalation
-
Edmonton, Alberta, CanadaStollery Children's Hospital
Dec 14, 2018